Our Focus on Immuno-Oncology
In the field of immuno-oncology, the STAM™ mouse is the most pathologically suitable model for developing new therapeutic drugs for liver cancer.
The utilization of STAM™ mouse enables non-clinical research for the development of liver cancer therapeutics targeting immune cells, tumor microenvironment, and genetic mutations.
EVENT
テストタグなしお知らせ
テストタグなしお知らせテストタグなしお知らせテストタグなしお知らせテストタグなしお知らせテストタグなしお知らせテストタグなしお知らせテストタグなしお知らせテストタグなしお知らせテストタグなしお知らせテストタグなしお知らせ…
Cell metab.,
“MGAT2 inhibitor decreases liver fibrosis and inflammation in murine NASH models and reduces body weight in human adults with obesity” (Cell Metab., DOI: 10.1016/j.cmet.2022.10.007., 2022)
